| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.7M | +63.4% |
| SG&A Expense | $4.0M | -8.5% |
| Operating Income | -$9.7M | -23.1% |
| Income Tax | $0 | — |
| Net Income | -$9.6M | -21.6% |
| EPS (Basic) | -$0.87 | +64.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.2M | -42.2% |
| Total Assets | $6.9M | -40.3% |
| Total Liabilities | $923K | -39.2% |
| Stockholders' Equity | $6.0M | -40.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.8M | -55.2% |
| Financing Cash Flow | $4.3M | -73.2% |